封面
市场调查报告书
商品编码
1409718

2024 年产前 DNA定序全球市场报告

Prenatal DNA Sequencing Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,产前DNA定序的市场规模迅速扩大。将从2023年的22.3亿美元扩大到2024年的25.6亿美元,复合年增长率为14.7%。过去一段时间的增长是由于患者偏好的变化、医学领域的进步和研究、非侵入性检测的增加、产妇年龄的增加以及产前 DNA定序的准确性和可靠性的提高。

产前 DNA定序市场规模预计在未来几年将快速成长。 2028年,将以15.5%的复合年增长率成长至45.6亿美元。预测期内的预期增长是由于消费者对早期检测的需求、孕产妇年龄的增加和相关怀孕风险、公共卫生倡议、监管机构的支持和对指南的遵守以及资料分析的进步。预测期内预期的显着趋势包括加强研究和开发、考虑伦理和法律规范、增强资料解释工具、整合精准医疗以及增加产前遗传咨询。

癌症发生率的预期上升将推动产前 DNA定序市场的成长。以不受控制的细胞生长和扩散为特征的癌症促使使用产前 DNA定序来检测胎儿非整倍体并识别胎儿癌症。这种定序方法揭示了影响人类对癌症易感性的遗传或种系 DNA 变化。例如,根据美国癌症协会2023年1月的资料,癌症患者人数从2021年的1,898,160人增加到2023年的1,958,310人,增加了3.16%。因此,癌症盛行率是推动产前 DNA定序市场的驱动力。

出生率的提高预计将促进产前 DNA定序市场的成长。出生率衡量的是特定人群和时间段内每 1,000 人的出生人数,这与使用产前 DNA定序来识别胎儿遗传异常的情况一致。这有助于做出明智的生殖决定并在分娩期间实施选择性干预措施。 2022年5月,美国疾病管制与预防中心(CDC)报告称,美国出生人数较2020年增加1%,2021年出生总合达到3,659,289人。 2021年整体出生率也成长了1%,每1000名15至44岁女性生育56.6个孩子。因此,出生率的上升是产前 DNA定序市场的推动要素。

2023年产前DNA定序市场最大的地区是北美。产前 DNA定序市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 产前DNA定序市场特点

第三章产前DNA定序市场趋势与策略

第四章产前DNA定序市场-宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章 全球产前DNA定序市场规模及成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章产前DNA定序市场区隔

  • 全球产前 DNA定序市场,按类型细分、实际和预测,2018-2023、2023-2028、2033
  • 遗传疾病
  • 非遗传性疾病
  • 全球产前 DNA定序市场,按应用、效能和预测细分,2018-2023、2023-2028、2033
  • 血友病
  • 唐氏症
  • 囊肿纤维化
  • 自闭症
  • 迪乔治症候群
  • 爱滋病(后天免疫力缺乏症候群)
  • 癌症
  • 其他用途
  • 全球产前 DNA定序市场,依最终用户细分,实际与预测,2018-2023、2023-2028、2033
  • 学术研究
  • 临床研究
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户

第七章产前 DNA定序市场区域与国家分析

  • 全球产前 DNA定序市场,按地区、实际和预测,2018-2023、2023-2028、2033
  • 全球产前 DNA定序市场(按国家/地区、实际情况和预测)2018-2023 年、2023-2028 年、2033 年

第八章亚太产前DNA定序市场

第九章中国产前DNA定序市场

第十章 印度产前DNA定序市场

第十一章 日本产前DNA定序市场

第十二章 澳洲产前DNA定序市场

第十三章 印尼产前DNA定序市场

第十四章 韩国产前DNA定序市场

第十五章 西欧产前DNA定序市场

第十六章英国产前DNA定序市场

第十七章 德国产前DNA定序市场

第十八章 法国产前DNA定序市场

第十九章 义大利产前DNA定序市场

第二十章 西班牙产前DNA定序市场

第21章 东欧产前DNA定序市场

第22章 俄罗斯产前DNA定序市场

第23章 北美产前DNA定序市场

第24章美国产前DNA定序市场

第25章 加拿大产前DNA定序市场

第26章 南美洲产前DNA定序市场

第27章 巴西产前DNA定序市场

第28章 中东产前DNA定序市场

第29章 非洲产前DNA定序市场

第30章产前DNA定序市场竞争形势及公司概况

  • 产前DNA定序市场竞争形势
  • 产前 DNA定序市场公司概况
    • Agilent Technologies Inc.
    • BGI Group
    • F. Hoffmann-La Roche Ltd
    • Illumina Inc.
    • Laboratory Corporation of America Holdings

第31章 全球产前DNA定序市场竞争基准化分析

第32章全球产前DNA定序市场竞争仪表板

第三十三章 产前DNA定序市场重大併购

第34章产前DNA定序市场未来展望及可能性分析

第35章附录

简介目录
Product Code: r11256

“Prenatal DNA Sequencing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dank sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dank sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The prenatal dank sequencing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Genetic Diseases; Nonhereditary Diseases
  • 2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorge Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications
  • 3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche Ltd; Illumina Inc.; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Prenatal DNA sequencing is a method employed to sequence the DNA of an unborn baby, utilizing a blood sample from the mother to unveil the complete genetic code of the fetus. This technique is instrumental in detecting fetal disorders or diseases.

The primary types of prenatal DNA sequencing encompass genetic diseases and nonhereditary diseases. Genetic diseases refer to disorders or diseases caused by mutations in one or more genes. DNA sequencing plays a crucial role in determining whether a gene carries a mutation leading to a specific disorder. Applications of prenatal DNA sequencing include conditions such as hemophilia, Down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others. Various users, including academic research, clinical research, hospitals and clinics, as well as pharmaceutical and biotechnology companies, employ this technology.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.23 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth observed in the historical period can be attributed to changes in patient preferences, advancements and research in the medical field, increased adoption of non-invasive testing, a rise in maternal age, and enhancements in the accuracy and reliability of prenatal DNA sequencing.

The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.56 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be attributed to consumer demand for early detection, an increase in maternal age and associated pregnancy risks, public health initiatives, support from regulatory bodies and adherence to guidelines, and advancements in data analysis. Noteworthy trends expected in the forecast period include intensified research and development efforts, considerations related to ethics and regulatory frameworks, enhancements in data interpretation tools, integration of precision medicine, and the promotion of prenatal genetic counseling.

The anticipated rise in cancer prevalence is set to drive the growth of the prenatal DNA sequencing market. Cancer, characterized by uncontrolled cell growth and spread, prompts the use of prenatal DNA sequencing to detect fetal aneuploidy and identify cancer in the fetus. This sequencing method unveils inherited or germline DNA changes influencing a person's cancer susceptibility. For example, data from the American Cancer Society in January 2023 showed an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth rate of 3.16%. Consequently, the prevalence of cancer acts as a driving force for the prenatal DNA sequencing market.

The expected increase in the birth rate is poised to contribute to the growth of the prenatal DNA sequencing market. Birth rate, indicating the number of live births per 1,000 people in a specified population and time period, aligns with the use of prenatal DNA sequencing to identify genetic abnormalities in unborn fetuses. This aids in making informed reproductive decisions and implementing selective interventions during birth. In May 2022, the Centers for Disease Control and Prevention (CDC) reported a 1% rise in U.S. births compared to 2020, reaching a total of 3,659,289 births in 2021. The overall fertility rate for 2021 also increased by 1%, standing at 56.6 births per 1,000 women aged 15-44. Thus, the higher birth rate acts as a driving factor for the prenatal DNA sequencing market.

Product innovation is a prominent trend in the prenatal DNA sequencing market, with major companies concentrating on developing innovative solutions to enhance their market standing. Juno Diagnostics, Inc., a U.S.-based health technology company, introduced the noninvasive prenatal screening test 'Hazel' in November 2022. Designed with no risk of miscarriage, the test can be performed as early as 9 weeks into pregnancy using a small blood sample. It screens for common genetic conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

Major companies in the prenatal DNA sequencing market are actively developing compliance solutions, such as CE-IVD compliance solutions, to offer a next-generation sequencing approach to noninvasive prenatal testing (NIPT). Illumina, a U.S.-based life science tools developer, partnered with Next Generation Genomic in June 2021 to launch VeriSeq NIPT Solution v2 in Thailand. This CE-IVD next-generation sequencing-based approach expands prenatal screening beyond common aneuploidies to rare autosomal aneuploidies, sex chromosome aneuploidies, and large partial duplications and deletions.

In November 2022, Myriad Genetics, Inc., a U.S.-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC, a personal genomics and prenatal DNA company. The undisclosed acquisition is expected to enhance Myriad's women's health product portfolio and provide access to personalized genetic tests, strengthening its position in the market.

Major companies operating in the prenatal dna sequencing market report are Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Genomic Health Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, Fluidigm Corp., GATC Biotech AG, GeneDx Inc., Genoma SA, Good Start Genetics Inc., Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc., KellBenx Inc., LifeCodexx AG .

North America was the largest region in the prenatal DNA sequencing market in 2023. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prenatal DNA sequencing market includes revenues earned by entities by provide services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Prenatal DNA Sequencing Market Size and Growth

  • 5.1. Global Prenatal DNA Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Prenatal DNA Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Prenatal DNA Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prenatal DNA Sequencing Market Segmentation

  • 6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genetic Diseases
  • Nonhereditary Diseases
  • 6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hemophilia
  • Down Syndrome
  • Cystic Fibrosis
  • Autism
  • DiGeorgre Syndrome
  • AIDS (Acquired Immunodeficiency Syndrome)
  • Cancer
  • Other Applications
  • 6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research
  • Clinical Research
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Prenatal DNA Sequencing Market Regional And Country Analysis

  • 7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

  • 8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prenatal DNA Sequencing Market

  • 9.1. China Prenatal DNA Sequencing Market Overview
  • 9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prenatal DNA Sequencing Market

  • 10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prenatal DNA Sequencing Market

  • 11.1. Japan Prenatal DNA Sequencing Market Overview
  • 11.2. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prenatal DNA Sequencing Market

  • 12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

  • 13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

  • 14.1. South Korea Prenatal DNA Sequencing Market Overview
  • 14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

  • 15.1. Western Europe Prenatal DNA Sequencing Market Overview
  • 15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prenatal DNA Sequencing Market

  • 16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prenatal DNA Sequencing Market

  • 17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prenatal DNA Sequencing Market

  • 18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prenatal DNA Sequencing Market

  • 19.1. Italy Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prenatal DNA Sequencing Market

  • 20.1. Spain Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prenatal DNA Sequencing Market

  • 21.1. Eastern Europe Prenatal DNA Sequencing Market Overview
  • 21.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prenatal DNA Sequencing Market

  • 22.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prenatal DNA Sequencing Market

  • 23.1. North America Prenatal DNA Sequencing Market Overview
  • 23.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prenatal DNA Sequencing Market

  • 24.1. USA Prenatal DNA Sequencing Market Overview
  • 24.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prenatal DNA Sequencing Market

  • 25.1. Canada Prenatal DNA Sequencing Market Overview
  • 25.2. Canada Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prenatal DNA Sequencing Market

  • 26.1. South America Prenatal DNA Sequencing Market Overview
  • 26.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prenatal DNA Sequencing Market

  • 27.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prenatal DNA Sequencing Market

  • 28.1. Middle East Prenatal DNA Sequencing Market Overview
  • 28.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prenatal DNA Sequencing Market

  • 29.1. Africa Prenatal DNA Sequencing Market Overview
  • 29.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal DNA Sequencing Market Competitive Landscape
  • 30.2. Prenatal DNA Sequencing Market Company Profiles
    • 30.2.1. Agilent Technologies Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. BGI Group
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Illumina Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Prenatal DNA Sequencing Market Competitive Benchmarking

32. Global Prenatal DNA Sequencing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Prenatal DNA Sequencing Market Future Outlook and Potential Analysis

  • 34.1 Prenatal DNA Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Prenatal DNA Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Prenatal DNA Sequencing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer